1. Home
  2. BWEN vs KPTI Comparison

BWEN vs KPTI Comparison

Compare BWEN & KPTI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BWEN
  • KPTI
  • Stock Information
  • Founded
  • BWEN N/A
  • KPTI 2008
  • Country
  • BWEN United States
  • KPTI United States
  • Employees
  • BWEN N/A
  • KPTI N/A
  • Industry
  • BWEN Industrial Machinery/Components
  • KPTI Biotechnology: Pharmaceutical Preparations
  • Sector
  • BWEN Industrials
  • KPTI Health Care
  • Exchange
  • BWEN Nasdaq
  • KPTI Nasdaq
  • Market Cap
  • BWEN 48.4M
  • KPTI 44.5M
  • IPO Year
  • BWEN N/A
  • KPTI 2013
  • Fundamental
  • Price
  • BWEN $2.13
  • KPTI $6.08
  • Analyst Decision
  • BWEN Strong Buy
  • KPTI Buy
  • Analyst Count
  • BWEN 1
  • KPTI 6
  • Target Price
  • BWEN $6.00
  • KPTI $39.80
  • AVG Volume (30 Days)
  • BWEN 159.9K
  • KPTI 97.1K
  • Earning Date
  • BWEN 11-12-2025
  • KPTI 11-04-2025
  • Dividend Yield
  • BWEN N/A
  • KPTI N/A
  • EPS Growth
  • BWEN N/A
  • KPTI N/A
  • EPS
  • BWEN N/A
  • KPTI N/A
  • Revenue
  • BWEN $145,141,000.00
  • KPTI $137,269,000.00
  • Revenue This Year
  • BWEN $8.75
  • KPTI $3.40
  • Revenue Next Year
  • BWEN $3.50
  • KPTI $9.69
  • P/E Ratio
  • BWEN N/A
  • KPTI N/A
  • Revenue Growth
  • BWEN N/A
  • KPTI N/A
  • 52 Week Low
  • BWEN $1.41
  • KPTI $3.51
  • 52 Week High
  • BWEN $3.03
  • KPTI $16.95
  • Technical
  • Relative Strength Index (RSI)
  • BWEN 46.98
  • KPTI 49.73
  • Support Level
  • BWEN $1.95
  • KPTI $6.15
  • Resistance Level
  • BWEN $2.37
  • KPTI $6.85
  • Average True Range (ATR)
  • BWEN 0.12
  • KPTI 0.51
  • MACD
  • BWEN 0.01
  • KPTI -0.16
  • Stochastic Oscillator
  • BWEN 42.86
  • KPTI 16.10

About BWEN Broadwind Inc.

Broadwind Inc is a precision manufacturer of structures, equipment and components for clean technology and other specialized applications. The company provide technologically high value products to customers with complex systems and stringent quality standards that operate in energy, mining and infrastructure sectors, in the United States of America. It capabilities include heavy fabrications, welding, metal rolling, coatings, gear cutting and shaping, gearbox manufacturing and repair, heat treat, assembly, engineering and packaging solutions. It operates through four operating segments namely Heavy Fabrications, Gearing, Industrial Solutions and Corporate.

About KPTI Karyopharm Therapeutics Inc.

Karyopharm Therapeutics Inc is a commercial-stage pharmaceutical company pioneering novel cancer therapies and dedicated to the discovery, development, and commercialization of drugs directed against nuclear export for the treatment of cancer and other diseases. XPOVIO (selinexor), is approved in the U.S. in multiple hematologic malignancy indications, including in combination with Velcade (bortezomib) and dexamethasone for the treatment of adult patients with multiple myeloma after at least one prior therapy, in combination with dexamethasone for the treatment of adult patients with heavily pretreated multiple myeloma and as a monotherapy for the treatment of adult patients with relapsed or refractory diffuse large B-cell lymphoma. The company derives its revenue from United States.

Share on Social Networks: